Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 25 | 2021 | 4226 | 1.370 |
Why?
|
| Tissue Donors | 9 | 2021 | 2319 | 0.830 |
Why?
|
| Hand-Assisted Laparoscopy | 1 | 2018 | 15 | 0.620 |
Why?
|
| Tissue and Organ Procurement | 4 | 2014 | 950 | 0.600 |
Why?
|
| Retroperitoneal Space | 1 | 2018 | 170 | 0.590 |
Why?
|
| Donor Selection | 2 | 2017 | 230 | 0.520 |
Why?
|
| Organ Transplantation | 3 | 2021 | 1154 | 0.520 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2018 | 373 | 0.490 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 636 | 0.460 |
Why?
|
| Nephrectomy | 1 | 2018 | 934 | 0.420 |
Why?
|
| Antibodies, Neoplasm | 4 | 2007 | 281 | 0.400 |
Why?
|
| Brain Death | 1 | 2014 | 356 | 0.370 |
Why?
|
| Kidney Failure, Chronic | 7 | 2019 | 2459 | 0.340 |
Why?
|
| Pancreas Transplantation | 2 | 2005 | 197 | 0.300 |
Why?
|
| Graft Rejection | 10 | 2014 | 4438 | 0.290 |
Why?
|
| Living Donors | 4 | 2018 | 639 | 0.270 |
Why?
|
| Kidney | 6 | 2016 | 7046 | 0.270 |
Why?
|
| Immunosuppressive Agents | 8 | 2014 | 4167 | 0.260 |
Why?
|
| Informed Consent | 1 | 2012 | 1006 | 0.250 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2006 | 67 | 0.250 |
Why?
|
| Biopsy | 4 | 2014 | 6765 | 0.240 |
Why?
|
| Graft Survival | 8 | 2021 | 3806 | 0.240 |
Why?
|
| Antibodies, Monoclonal | 6 | 2011 | 9176 | 0.190 |
Why?
|
| Death | 2 | 2019 | 676 | 0.180 |
Why?
|
| Cytomegalovirus Infections | 1 | 2006 | 831 | 0.160 |
Why?
|
| Transplants | 1 | 2021 | 206 | 0.160 |
Why?
|
| Antilymphocyte Serum | 2 | 2011 | 483 | 0.160 |
Why?
|
| Hyperammonemia | 1 | 2019 | 76 | 0.160 |
Why?
|
| HLA Antigens | 3 | 2014 | 1371 | 0.150 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2014 | 1351 | 0.150 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2021 | 738 | 0.130 |
Why?
|
| Desensitization, Immunologic | 2 | 2014 | 541 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15626 | 0.130 |
Why?
|
| Ferrosoferric Oxide | 1 | 2016 | 348 | 0.120 |
Why?
|
| Capillaries | 1 | 2016 | 755 | 0.110 |
Why?
|
| Histocompatibility | 1 | 2014 | 317 | 0.110 |
Why?
|
| Informed Consent By Minors | 1 | 2012 | 9 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2005 | 5966 | 0.100 |
Why?
|
| Plasmapheresis | 2 | 2014 | 206 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 3734 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 2014 | 788 | 0.090 |
Why?
|
| Isoantibodies | 1 | 2014 | 674 | 0.090 |
Why?
|
| Blood Group Incompatibility | 1 | 2010 | 136 | 0.090 |
Why?
|
| Personal Autonomy | 1 | 2012 | 304 | 0.080 |
Why?
|
| BK Virus | 1 | 2010 | 123 | 0.080 |
Why?
|
| Pancreas | 2 | 2005 | 1684 | 0.080 |
Why?
|
| Fluoroquinolones | 1 | 2010 | 308 | 0.080 |
Why?
|
| Polyomavirus Infections | 1 | 2010 | 194 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 1598 | 0.070 |
Why?
|
| Stem Cells | 2 | 2021 | 3521 | 0.070 |
Why?
|
| Ventilator Weaning | 1 | 2008 | 163 | 0.070 |
Why?
|
| Monocytes | 3 | 2007 | 2573 | 0.070 |
Why?
|
| Mycophenolic Acid | 2 | 2011 | 347 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3439 | 0.070 |
Why?
|
| Complement C4b | 1 | 2007 | 132 | 0.070 |
Why?
|
| Histocompatibility Testing | 1 | 2008 | 719 | 0.070 |
Why?
|
| Length of Stay | 2 | 2018 | 6410 | 0.070 |
Why?
|
| Acute Kidney Injury | 2 | 2016 | 1925 | 0.060 |
Why?
|
| Immune System | 1 | 2010 | 794 | 0.060 |
Why?
|
| Wound Healing | 1 | 2016 | 2799 | 0.060 |
Why?
|
| Female | 22 | 2019 | 391766 | 0.060 |
Why?
|
| Cryptococcus neoformans | 1 | 2006 | 121 | 0.060 |
Why?
|
| Contrast Media | 2 | 2016 | 5309 | 0.060 |
Why?
|
| Raffinose | 1 | 2004 | 53 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 2217 | 0.060 |
Why?
|
| Procaine | 1 | 2004 | 60 | 0.060 |
Why?
|
| Humans | 31 | 2021 | 760239 | 0.060 |
Why?
|
| Potassium Chloride | 1 | 2004 | 230 | 0.060 |
Why?
|
| Organ Preservation Solutions | 1 | 2004 | 100 | 0.060 |
Why?
|
| Transplantation, Homologous | 2 | 2019 | 4808 | 0.060 |
Why?
|
| Mannitol | 1 | 2004 | 180 | 0.060 |
Why?
|
| Perception | 1 | 2010 | 1195 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2012 | 2770 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 39067 | 0.060 |
Why?
|
| Retrospective Studies | 10 | 2021 | 80414 | 0.060 |
Why?
|
| Male | 21 | 2018 | 359943 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2008 | 1397 | 0.060 |
Why?
|
| Minority Groups | 1 | 2010 | 1201 | 0.050 |
Why?
|
| Allopurinol | 1 | 2004 | 198 | 0.050 |
Why?
|
| Lymphocytes | 2 | 2008 | 2611 | 0.050 |
Why?
|
| Adult | 18 | 2018 | 220718 | 0.050 |
Why?
|
| Prognosis | 3 | 2019 | 29547 | 0.050 |
Why?
|
| Hypotension | 1 | 2008 | 879 | 0.050 |
Why?
|
| Glutathione | 1 | 2004 | 583 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 2152 | 0.050 |
Why?
|
| Lupus Nephritis | 1 | 2005 | 318 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 2242 | 0.050 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2006 | 515 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4747 | 0.050 |
Why?
|
| Middle Aged | 17 | 2014 | 220307 | 0.040 |
Why?
|
| Treatment Outcome | 8 | 2021 | 64583 | 0.040 |
Why?
|
| Adenosine | 1 | 2004 | 804 | 0.040 |
Why?
|
| Radiographic Image Enhancement | 2 | 2016 | 876 | 0.040 |
Why?
|
| Antigens, CD34 | 2 | 2016 | 658 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2010 | 1847 | 0.040 |
Why?
|
| Aged | 11 | 2019 | 168773 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2010 | 3066 | 0.040 |
Why?
|
| United States | 6 | 2021 | 72181 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2014 | 664 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2008 | 2332 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 3344 | 0.030 |
Why?
|
| Renal Artery | 1 | 2016 | 351 | 0.030 |
Why?
|
| Age Factors | 4 | 2014 | 18369 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5104 | 0.030 |
Why?
|
| Rabbits | 2 | 2011 | 4780 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 2007 | 282 | 0.030 |
Why?
|
| Endothelium | 1 | 2016 | 764 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2014 | 201 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 544 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2011 | 12917 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 728 | 0.030 |
Why?
|
| Glucose | 1 | 2004 | 4342 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2005 | 2162 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 1340 | 0.030 |
Why?
|
| Radioisotope Renography | 1 | 2012 | 61 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2021 | 2300 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6472 | 0.020 |
Why?
|
| Exosomes | 1 | 2016 | 424 | 0.020 |
Why?
|
| Thrombosis | 1 | 2006 | 2940 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 727 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2016 | 2113 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 694 | 0.020 |
Why?
|
| Creatinine | 1 | 2016 | 1898 | 0.020 |
Why?
|
| Adolescent | 5 | 2014 | 88173 | 0.020 |
Why?
|
| Antigens, CD | 3 | 2007 | 4000 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2010 | 138 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 1411 | 0.020 |
Why?
|
| Insulin | 1 | 2004 | 6589 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 30025 | 0.020 |
Why?
|
| Boston | 2 | 2014 | 9324 | 0.020 |
Why?
|
| Time Factors | 4 | 2014 | 39928 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20550 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 36351 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2011 | 733 | 0.020 |
Why?
|
| Child | 2 | 2014 | 80070 | 0.020 |
Why?
|
| Viremia | 1 | 2010 | 707 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 2252 | 0.020 |
Why?
|
| Glycoproteins | 2 | 2005 | 2207 | 0.020 |
Why?
|
| Antigens, Neoplasm | 2 | 2005 | 1994 | 0.020 |
Why?
|
| Glomerular Basement Membrane | 1 | 2006 | 36 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 12420 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 2604 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2014 | 879 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5233 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2014 | 41340 | 0.020 |
Why?
|
| Safety | 1 | 2010 | 1147 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2007 | 602 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2007 | 449 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3416 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5199 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2007 | 583 | 0.010 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2006 | 165 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4413 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2014 | 2726 | 0.010 |
Why?
|
| Necrosis | 1 | 2007 | 1604 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8522 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 2171 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10074 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 4371 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2011 | 2160 | 0.010 |
Why?
|
| Risk Factors | 3 | 2014 | 73999 | 0.010 |
Why?
|
| Microcirculation | 1 | 2006 | 1269 | 0.010 |
Why?
|
| Viral Load | 1 | 2010 | 3329 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2016 | 3796 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 1328 | 0.010 |
Why?
|
| Medical Records | 1 | 2005 | 1407 | 0.010 |
Why?
|
| Prednisone | 1 | 2004 | 1563 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 18960 | 0.010 |
Why?
|
| Young Adult | 2 | 2014 | 59054 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2006 | 1174 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15818 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2004 | 1470 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18218 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 12050 | 0.010 |
Why?
|
| Animals | 3 | 2016 | 168245 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 7230 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 8964 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2004 | 2242 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 14564 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12697 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 20076 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6297 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2008 | 8476 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2006 | 9304 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 21308 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 58838 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 81406 | 0.010 |
Why?
|
| Neoplasms | 1 | 2014 | 22077 | 0.000 |
Why?
|
| Pregnancy | 1 | 2006 | 29822 | 0.000 |
Why?
|
Concepts
(189)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_